Else Kröner Research School “Molecular Therapy and Prediction in Gastrointestinal Malignoma”

The Else Kröner-Research School aims to promote the career of young physicians as so-called Clinician Scientists, who combine patient care and medical research.

The scholars develop research projects, in which basic research is interlinked with clinical questions. The findings are translated into improved patient care in the field of gastrointestinal malignoma.

The Research school provides protected time for research and intensive supervision and mentoring as well as further education and training.

Development of therapeutic peptides for the treatment of Alzheimer’s disease

In brains of patients suffering from Alzheimer’s disease increased levels of aggregated tau and amyloid-beta protein can be observed. In the underlying processes, modifications of these proteins, like phosphorylation, play a crucial role. Our novel therapeutic approach does not target inhibition of the activity of the (co-)responsible enzymes CK1δ and CK1ε in general, but will block their interactions with specific cellular proteins. This is made possible by using short protein fragments, so called peptides.

PAROCARD: Oral health and intima-media thickness. A population-representative study of the association between oral health and a surrogate marker for cardiovascular disease.

Many people suffer from cardiovascular disease in their lives. It has been shown that elevated levels of the inflammatory marker C-reactive protein (CRP) are associated with an increased risk of cardiovascular disease. Very high levels of CRP often occur in patients with oral inflammation such as periodontitis and gingivitis. Therefore, in the context of the PAROCARD Study, we investigate whether periodontitis and / or gingivitis are associated with atherosclerotic changes in the vascular wall.

The role of the coagulation system in the normal and leukaemic haematopoietic stem cell niche

The bone marrow microenvironment (BMM) represents the ‘home’ for normal haematopoietic stem cells (HSC) or blood stem cells, which give rise to all the various blood cells. The respective interplay between the BMM and HSC is slowly being elucidated, but evidence for a definitive role of the proteins of the blood clotting system for the control of haematopoietic homeostasis is scarce and non-existent in the case of leukaemia, a malignant disease of HSC. 

Influence of thyroid hormones on brain, cognition and behaviour

In our project our subjects experience either too much, or too little thyroid hormones in their body for a certain period of time. Before and after this time period, we examine their cognition and perform an extensive neuroimaging. We are thereby able to identify the area in the brain which is altered by changes of thyroid hormone household. Additionally, we examine patients with a variation of thyroid hormone receptors in the brain. We are interested to analyse the areas of the brain causing the symptoms, possibly leading to therapies targeting these receptors. 

Fetal programming: Evaluation of cardiovascular remodeling in late-onset small-for-gestational-age fetuses and prediction of adverse birth and intermediate-term cardiovascular outcome- CURIOSA study

Clinical studies over the last decade have demonstrated that on average SGA (small for gestational age) fetuses show signs of cardiovascular remodeling and have higher postnatal cardiovascular risks. Newer findings suggest that SGA induces primary cardiac and vascular changes that could explain the increased predisposition to cardiovascular disease in adult life even.

Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS Iymphoma patients - MARTA trial

Primary central nervous system lymphoma (PCNSL) is an aggressive mature lymphoma of the diffuse-large B cell type which exclusively manifests in the central nervous system compartment. Patients > 60 years compromise > 50% of the PCNSL patients. During the last years progress has been made in prolonging  survival,  reducing  toxicity  and  improving  quality  of  life  for  this  challenging subgroup of patients. But in contrast to the younger patients we are still facing a palliative treatment approach. 

Targeting immune-lipid crosstalk in cardio-metabolic diseases: focus on HDL dependent regulation of chemokine-receptor signaling

Cardiovascular diseases are the leading cause of death worldwide. This is generally attributable to an underlying pathology called atherosclerosis. There is accumulating evidence that two main causative factors of atherosclerosis, being disturbances in the lipids and inflammation, are intermingled. Previously, small experiments confirmed that lipids and inflammation can influence each other. In these experiments, I focused on a specific part of the inflammatory system (chemokines) and lipids, called high-density lipoproteins (HDL).

Preemptive immunotherapy with IL-15 activated cytokine-induced killer cells (CIK cells) for prevention of relapse in high-risk patients with acute leukemia and myelodysplastic syndromes after allogeneic stem cell transplantation

Cytokine-induced killer (CIK) cells are a diverse group of immune cells consisting of T-lymphocytes and natural killer cells, which can be produced from mononuclear cells of a stem cell donor in 10-12 days. Administration of CIK-Cells may help to prevent the recurrence of malignant blood system disorders in patients who already underwent stem cell transplantation. This research study on the efficacy of CIK cells is carried out in close cooperation with the pediatric hospitals of Dusseldorf and Heidelberg as well as the medical centers in Frankfurt and Mainz.